The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
Unique opportunity to acquire a rapidly scaling, fully remote telemedicine and digital prescription, GDPR-compliant platform operating under the EU cross-border framework. The business connects over 20,000 patients with licensed doctors and pharmacies in Germany
Licence(s) Held
Operates under EU cross-border telemedicine framework (Physicians licensed in Germany & Poland). GDPR-compliant platform. No direct cannabis handling license required.
Listing Details
Cyprus-based company operates a fully digital telemedicine platform, enabling remote consultations and digital prescriptions
Launched in 2024, the platform has served approximately 20,000 patients and processed over 6,500 prescriptions per month
Focused on deep process optimization to ensure scalability before launching targeted marketing campaigns, including Facebook advertising and affiliate marketing, and continues to implement new features to enhance user experience
Profitable business with margins exceeding 60%, a current revenue run rate of ~€140,000 per month, and a forecasted €1.5M by year-end, reflecting ~20% annual growth
Income is generated through patient appointment bookings, marketing services for pharmacies, partnerships with leading producers, and white-label product offerings.
Operates efficiently with ~12 staff/freelancers, leveraging front-end and back-end freelance specialists
Automated workflows reduce doctor consultation time by 90%, and the platform supports white-label functionality for rapid B2B expansion
Projected annual growth of 15–20% is driven by rising patient demand and recent liberalization of the German cannabis market
Seeking full sale and includes the going concern business, intellectual property, brand, patient database, and software codebase
Unique opportunity to acquire a rapidly scaling, fully remote telemedicine and digital prescription, GDPR-compliant platform operating under the EU cross-border framework. The business connects over 20,000 patients with licensed doctors and pharmacies in Germany
Licence(s) Held
Operates under EU cross-border telemedicine framework (Physicians licensed in Germany & Poland). GDPR-compliant platform. No direct cannabis handling license required.
Listing Details
Cyprus-based company operates a fully digital telemedicine platform, enabling remote consultations and digital prescriptions
Launched in 2024, the platform has served approximately 20,000 patients and processed over 6,500 prescriptions per month
Focused on deep process optimization to ensure scalability before launching targeted marketing campaigns, including Facebook advertising and affiliate marketing, and continues to implement new features to enhance user experience
Profitable business with margins exceeding 60%, a current revenue run rate of ~€140,000 per month, and a forecasted €1.5M by year-end, reflecting ~20% annual growth
Income is generated through patient appointment bookings, marketing services for pharmacies, partnerships with leading producers, and white-label product offerings.
Operates efficiently with ~12 staff/freelancers, leveraging front-end and back-end freelance specialists
Automated workflows reduce doctor consultation time by 90%, and the platform supports white-label functionality for rapid B2B expansion
Projected annual growth of 15–20% is driven by rising patient demand and recent liberalization of the German cannabis market
Seeking full sale and includes the going concern business, intellectual property, brand, patient database, and software codebase
MergersCorp M&A International As Seen On
Security Verification
For security purposes, please solve this simple puzzle to verify you are human before sending an OTP.
Description
Unique opportunity to acquire a rapidly scaling, fully remote telemedicine and digital prescription, GDPR-compliant platform operating under the EU cross-border framework. The business connects over 20,000 patients with licensed doctors and pharmacies in Germany
Licence(s) Held
Operates under EU cross-border telemedicine framework (Physicians licensed in Germany & Poland). GDPR-compliant platform. No direct cannabis handling license required.
Listing Details
Cyprus-based company operates a fully digital telemedicine platform, enabling remote consultations and digital prescriptions
Launched in 2024, the platform has served approximately 20,000 patients and processed over 6,500 prescriptions per month
Focused on deep process optimization to ensure scalability before launching targeted marketing campaigns, including Facebook advertising and affiliate marketing, and continues to implement new features to enhance user experience
Profitable business with margins exceeding 60%, a current revenue run rate of ~€140,000 per month, and a forecasted €1.5M by year-end, reflecting ~20% annual growth
Income is generated through patient appointment bookings, marketing services for pharmacies, partnerships with leading producers, and white-label product offerings.
Operates efficiently with ~12 staff/freelancers, leveraging front-end and back-end freelance specialists
Automated workflows reduce doctor consultation time by 90%, and the platform supports white-label functionality for rapid B2B expansion
Projected annual growth of 15–20% is driven by rising patient demand and recent liberalization of the German cannabis market
Seeking full sale and includes the going concern business, intellectual property, brand, patient database, and software codebase
Basic Details
Target Price:
$ 0
Gross Revenue
$1,680,000
EBITDA
$1,008,000
Business ID:
L#20261003
Country
Cyprus
Detail
Similar Businesses
Published on February 12, 2026 at 10:49 am. Updated on February 12, 2026 at 10:49 am
Profitable, veteran-focused virtual medical cannabis clinic in Canada
TBD
Health Care Businesses
PREVIOUS PROPERTY
Subsoil Use Rights for Aktobe Oilfield Redevelopment (1.5M Tons B+C1)
NEXT PROPERTY
Profitable, veteran-focused virtual medical cannabis clinic in Canada